image
Healthcare - Biotechnology - NASDAQ - US
$ 21.06
1.1 %
$ 1.03 B
Market Cap
-11.14
P/E
Price Target Average
72.13%
Revenue Forecast Estimate
-0.00%
EBIT Estimate
25.99%
Net Income Estimate
--13.74%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets Enliven Therapeutics, Inc.
image
Wall Street analysts predict an average 1-year price target for ELVN of $36.2 , with forecasts ranging from a low of $32 to a high of $40 .
ELVN Lowest Price Target Wall Street Target
32 USD 51.95%
ELVN Average Price Target Wall Street Target
36.2 USD 72.13%
ELVN Highest Price Target Wall Street Target
40 USD 89.93%
REVENUE FORECAST

Revenue Forecast Chart ELVN

image
EBIT FORECAST

EBIT Forecast Chart ELVN

image
NET INCOME FORECAST

Net Income Chart ELVN

image